Natalie A Stephens1, Hui Xie1, Neil M Johannsen2, Timothy S Church3, Steven R Smith1, Lauren M Sparks4. 1. Translational Research Institute for Metabolism and Diabetes, Florida Hospital, Orlando, FL, USA; Diabetes and Obesity Research Center, Sanford-Burnham Medical Research Institute, Orlando, FL, USA. 2. Pennington Biomedical Research Center, Department of Preventive Medicine, Baton Rouge, LA, USA; Louisiana State University, Department of Kinesiology, Baton Rouge, LA, USA. 3. Pennington Biomedical Research Center, Department of Preventive Medicine, Baton Rouge, LA, USA. 4. Translational Research Institute for Metabolism and Diabetes, Florida Hospital, Orlando, FL, USA; Diabetes and Obesity Research Center, Sanford-Burnham Medical Research Institute, Orlando, FL, USA. Electronic address: Lauren.Sparks@flhosp.org.
Abstract
AIMS/HYPOTHESIS: Exercise benefits most, but not all, individuals with type 2 diabetes mellitus (T2DM). The aim of this study was to determine whether a proportion of individuals with T2DM would fail to demonstrate exercise-induced metabolic improvements. We hypothesized that this lack of response would be related to their skeletal muscle transcriptional profile. METHODS: 42 participants with T2DM from the previously reported HART-D study underwent a 9-month supervised exercise intervention. We performed a principal components analysis to distinguish Responders from Non-Responders (n=9 each) based on: decreases in (1) HbA1c, (2) %fat (3) BMI and (4) increase in skeletal muscle mtDNA. mRNA expression patterns in muscle tissue at baseline were assessed by microarray and qRT-PCR analysis in both groups. RESULTS: Of 186 genes identified by microarray analysis, 70% were up-regulated in Responders and down-regulated in Non-Responders. Several genes involved in substrate metabolism and mitochondrial biogenesis were significantly different (fold-change>1.5, p<0.05) between the groups at baseline, indicating a blunted oxidative capacity at baseline in Non-Responders. CONCLUSIONS/INTERPRETATIONS: These data suggest that a unique baseline expression pattern of genes involved in muscle fuel metabolism may predict an individual's lack of exercise response in metabolic outcomes, thus allowing exercise interventions to be targeted to these individuals and aid in the identification of novel approaches to treat Non-Responders in the future.
AIMS/HYPOTHESIS: Exercise benefits most, but not all, individuals with type 2 diabetes mellitus (T2DM). The aim of this study was to determine whether a proportion of individuals with T2DM would fail to demonstrate exercise-induced metabolic improvements. We hypothesized that this lack of response would be related to their skeletal muscle transcriptional profile. METHODS: 42 participants with T2DM from the previously reported HART-D study underwent a 9-month supervised exercise intervention. We performed a principal components analysis to distinguish Responders from Non-Responders (n=9 each) based on: decreases in (1) HbA1c, (2) %fat (3) BMI and (4) increase in skeletal muscle mtDNA. mRNA expression patterns in muscle tissue at baseline were assessed by microarray and qRT-PCR analysis in both groups. RESULTS: Of 186 genes identified by microarray analysis, 70% were up-regulated in Responders and down-regulated in Non-Responders. Several genes involved in substrate metabolism and mitochondrial biogenesis were significantly different (fold-change>1.5, p<0.05) between the groups at baseline, indicating a blunted oxidative capacity at baseline in Non-Responders. CONCLUSIONS/INTERPRETATIONS: These data suggest that a unique baseline expression pattern of genes involved in muscle fuel metabolism may predict an individual's lack of exercise response in metabolic outcomes, thus allowing exercise interventions to be targeted to these individuals and aid in the identification of novel approaches to treat Non-Responders in the future.
Authors: James A Timmons; Steen Knudsen; Tuomo Rankinen; Lauren G Koch; Mark Sarzynski; Thomas Jensen; Pernille Keller; Camilla Scheele; Niels B J Vollaard; Søren Nielsen; Thorbjörn Akerström; Ormond A MacDougald; Eva Jansson; Paul L Greenhaff; Mark A Tarnopolsky; Luc J C van Loon; Bente K Pedersen; Carl Johan Sundberg; Claes Wahlestedt; Steven L Britton; Claude Bouchard Journal: J Appl Physiol (1985) Date: 2010-02-04
Authors: Edward W Gregg; Xiaohui Zhuo; Yiling J Cheng; Ann L Albright; K M Venkat Narayan; Theodore J Thompson Journal: Lancet Diabetes Endocrinol Date: 2014-08-12 Impact factor: 32.069
Authors: Ronald J Sigal; Angela S Alberga; Gary S Goldfield; Denis Prud'homme; Stasia Hadjiyannakis; Réjeanne Gougeon; Penny Phillips; Heather Tulloch; Janine Malcolm; Steve Doucette; George A Wells; Jinhui Ma; Glen P Kenny Journal: JAMA Pediatr Date: 2014-11 Impact factor: 16.193
Authors: Lauren M Sparks; Neil M Johannsen; Timothy S Church; Conrad P Earnest; Esther Moonen-Kornips; Cedric Moro; Matthijs K C Hesselink; Steven R Smith; Patrick Schrauwen Journal: J Clin Endocrinol Metab Date: 2013-03-05 Impact factor: 5.958
Authors: Gertrud Kacerovsky-Bielesz; Marek Chmelik; Charlotte Ling; Rochus Pokan; Julia Szendroedi; Michaela Farukuoye; Michaela Kacerovsky; Albrecht I Schmid; Stephan Gruber; Michael Wolzt; Ewald Moser; Giovanni Pacini; Gerhard Smekal; Leif Groop; Michael Roden Journal: Diabetes Date: 2009-03-05 Impact factor: 9.461
Authors: J Matthew Hinkley; Kai Zou; Sanghee Park; Kristen Turner; Donghai Zheng; Joseph A Houmard Journal: Am J Physiol Endocrinol Metab Date: 2017-05-09 Impact factor: 4.310
Authors: Melissa L Erickson; Jacob M Allen; Daniel P Beavers; Linda M Collins; Karina W Davidson; Kirk I Erickson; Karyn A Esser; Matthijs K C Hesselink; Kerrie L Moreau; Eric B Laber; Charlotte A Peterson; Courtney M Peterson; Jane E Reusch; John P Thyfault; Shawn D Youngstedt; Juleen R Zierath; Bret H Goodpaster; Nathan K LeBrasseur; Thomas W Buford; Lauren M Sparks Journal: Geroscience Date: 2022-10-15 Impact factor: 7.581
Authors: Stephan Nieuwoudt; Ciarán E Fealy; Julie A Foucher; Amanda R Scelsi; Steven K Malin; Mangesh Pagadala; Michael Rocco; Bartolome Burguera; John P Kirwan Journal: Am J Physiol Endocrinol Metab Date: 2017-05-16 Impact factor: 4.310